By Django Gold ( May 30, 2012, 2:52 PM EDT) -- Tekmira Pharmaceuticals Corp. on Tuesday sought the disqualification of Alnylam Pharmaceuticals Inc. counsel McDermott Will & Emery LLP, saying that a McDermott attorney's past work for Tekmira represents a conflict of interest with Alnylam's molecule patent infringement case against the genetics company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.